These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29944521)

  • 1. US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs.
    Almeter PJ; Labuhn JA; Morris PE; Hessel EA
    Anesth Analg; 2018 Dec; 127(6):1414-1420. PubMed ID: 29944521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Costs of FDA Approval for Formerly Unapproved Marketed Drugs.
    Hakim A; Gupta R; Ross JS
    JAMA; 2017 Dec; 318(22):2181-2182. PubMed ID: 29131905
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018.
    Alpern JD; Shahriar AA; Xi M; Thapa S; Kodet AJ; Stauffer WM; Vazquez Benitez G; Pawloski PA; Dehmer SP
    JAMA Netw Open; 2020 Aug; 3(8):e2013595. PubMed ID: 32804216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinflation-Definitions and Causes.
    Saltiel M; Finnefrock M
    J Pharm Pract; 2018 Aug; 31(4):370-373. PubMed ID: 29905083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
    Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
    JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic medications for hepatitis C.
    Jensen DM; Sebhatu P; Reau NS
    Liver Int; 2016 Jul; 36(7):925-8. PubMed ID: 27306302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinflation: Definitions and Causes.
    Saltiel M; Finnefrock M
    J Pharm Pract; 2020 Apr; 33(2):183-186. PubMed ID: 30099947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.
    Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS
    Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shake Up in the Neostig- mine Methylsulfate Cholin- esterase Inhibitor Market for Neuromuscular Block Reversal.
    Welliver M
    AANA J; 2015 Aug; 83(4):240-2. PubMed ID: 26390739
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales.
    Sharma D; Schumock GT; Saffore CD; Albert Edwards S; Walton SM
    Ther Innov Regul Sci; 2020 Mar; 54(2):424-430. PubMed ID: 32072591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
    Kelton CM; Chang LV; Guo JJ; Yu Y; Berry EA; Bian B; Heaton PC
    Appl Health Econ Health Policy; 2014 Apr; 12(2):165-77. PubMed ID: 24550087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Market Competition on Tetracycline Pricing and Impact of Price Increases on Clinician Prescribing Behavior.
    Barbieri JS; Margolis DJ; Brod BA
    J Invest Dermatol; 2017 Dec; 137(12):2491-2496. PubMed ID: 28842326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price survey. Generic drug market heats up.
    Hosp Mater Manage; 2001 Mar; 26(3):1, 12-3. PubMed ID: 11975141
    [No Abstract]   [Full Text] [Related]  

  • 16. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectories of Injectable Cancer Drug Costs After Launch in the United States.
    Gordon N; Stemmer SM; Greenberg D; Goldstein DA
    J Clin Oncol; 2018 Feb; 36(4):319-325. PubMed ID: 29016226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering generic drug prices: less regulation equals more competition.
    Anis AH; Guh DP; Woolcott J
    Med Care; 2003 Jan; 41(1):135-41. PubMed ID: 12544550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and technological drivers of generic sterile injectable drug shortages.
    Woodcock J; Wosinska M
    Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do pharmaceuticals really cost in the long run?
    Lakdawalla D; MacEwan JP; Dubois R; Westrich K; Berdud M; Towse A
    Am J Manag Care; 2017 Aug; 23(8):488-493. PubMed ID: 29087143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.